---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-257417"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2026-06-04T20:14:44+00:00"
generated_at: "2026-06-04T20:45:32.969729+00:00"
event_type: "other"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CV Sciences shareholders reject reverse stock split; three directors elected

## Summary
- Proposal 2 (reverse stock split up to 1-for-800) failed: 48.5M for, 59.6M against, 8.1M abstain.
- Directors elected: Dr. Jamie Corroon (39.5M for), Joseph Dowling (37.7M for), Bill McCorkle (22.7M for, 17.2M abstain).
- Ratification of Haskell & White as auditor passed with 102.4M for vs 12.5M against.
- Quorum of 60.1% achieved with 116.2M shares represented at the virtual annual meeting.

## SEC filing metadata
- accession: 0001193125-26-257417
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2026-06-04T20:14:44+00:00
- event_type: other
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000119312526257417/0001193125-26-257417-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000119312526257417/cvsi-20250602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-257417
- JSON: https://secwatch.observer/filing/0001193125-26-257417.json
- Plain text: https://secwatch.observer/filing/0001193125-26-257417.txt

## Key facts
- Shareholder Votes
  CV Sciences, Inc. shareholders rejected Reverse Stock Split at the 2026-06-02 meeting.
  - Proposal: reverse split
  - Outcome: failed
  - Meeting: 2026-06-02
  source text: Proposal 2 - Reverse Stock Split The Company's stockholders did not approve the Company's proposal to amend its Certificate of Incorporation, as amended to effect, at the discretion of the Board of Directors, a reverse stock split of all outstanding shares of common stock at a ratio of not less than 1-for-10 and not greater than 1-for-800, such ratio to be determined by the Board of Directors at any time before May 30, 2029, without further approval or authorization from its stockholders, as set forth below: FOR AGAINST ABSTAIN BROKER NON-VOTE 48,496,747 59,628,926 8,109,111 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000119312526257417/0001193125-26-257417-index.htm
- Shareholder Votes
  CV Sciences, Inc. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2026-06-02 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: Proposal 3 - Ratification of Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified Haskell & White LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, as set forth below: FOR AGAINST ABSTAIN BROKER NON-VOTE 102,384,289 12,488,529 1,361,966 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000119312526257417/0001193125-26-257417-index.htm
- Shareholder Votes
  CV Sciences, Inc. shareholders approved Election of Directors at the 2026-06-02 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-02
  source text: Proposal 1 - Election of Directors The Company's stockholders elected three directors, each to serve until the Company's next Annual Meeting of Stockholders or until his successor is duly elected and qualified, subject to prior death, resignation or removal, as set forth below: NAME FOR AGAINST ABSTAIN BROKER NON-VOTE Dr. Jamie Corroon 39,505,495 3,183,772 1,078,738 72,466,779 Joseph Dowling 37,674,977 4,813,319 1,279,709 72,466,779 Bill McCorkle 22,671,092 3,928,542 17,168,371 72,466,779
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000119312526257417/0001193125-26-257417-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.